MedTrace Logo

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

NCT05102318 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-02-11

No results posted yet for this study

Summary

The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Conditions

  • Pulp Disease, Dental

Interventions

PROCEDURE

Direct Pulp Capping

Direct Pulp Capping

PROCEDURE

Partial Pulpotomy

Partial Pulpotomy

PROCEDURE

Pulpotomy

Pulpotomy

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • British University In Egypt

    lead OTHER

Principal Investigators

  • Noha Kabil, Professor · British University In Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2022-04-01
Completion
2022-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05102318 on ClinicalTrials.gov